İxtisası: Daxili Xəstəliklər və Revmatologiya Uzmanı
Təhsili: 2005-2011 - Azərbaycan Tibb Universiteti Müalicə İşi və Profilaktika Fakültəsi 2013-2017 -  İstanbul Tibb Fakültəsi Daxili Xəstəliklər Kafedrasında uzmanlıq təhsili 2018-2022 - İstanbul Tibb Fakültəsi Revmatologiya şöbəsinde yandal uzmanlıq təhsili
Dərc olunan məqalələr:
1. Reinfection with SARS‐CoV‐2 in a kidney transplant recipient. Amikishiyev Shirkhan, Demir Erol, Aghamuradov Sarvan, et al Transplant Infectious Disease 2021.
2. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls. Ali Mert, Haluk Vahaboğlu, Ferhat
Arslan, Ayşe Batirel, Kemal Tolga Saraçoğlu, Aliye Bastug, Atahan Çağatay, İlim Irmak, Gülçin Telli Dizman, İhsan Ertenli, Lütfye Nilsun Altunal, Buket Ertürk Sengel, Mehmet Bayram, Ahmet Omma, Shirkhan Amikishiyev et all. Rheumatology international 2021:1-11.
3. Malnutrition treatment and follow-up in Clinical Nutrition Outpatient Clinic was associated with increased muscle mass. Bulent Saka, Murat Bektas, Oguz Kagan Bakkaloglu, Shirkhan Amikishiyev et al. Nutrition 2022:111680.
4. Hypovitaminosis D is associated with endothelial dysfunction in patients with metabolic syndrome. U Oruc Coşkun, E Akpinar Yunus, Amikishiyev Shirkhan, et al. Current Vascular Pharmacology 2017;15:152-7.
5. Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome. Coskun U.Oruc, Yunus E. Akpinar, Elmire Dervisoglu, Shirkhan Amikishiyev et.all Clinical Chemistry and Laboratory Medicine (CCLM) 2017;55:139-44.
6. Acquired FVIII and FIX inhibitors after pregnancy: a case report. Kose M, Bakkaloglu OK, Amikishiyev S, et al. Acta haematologica 2016;136:229-32.
7. Tümör nekrozis faktör-alfa inhibitörü tedavisi gereken aksiyel spondiloartritli hastalarda klinik özellikler ve tedavi sonuçları. Ulusal Romatoloji Dergisi / Journal of Turkish Society for Rheumatology • Cilt / Volume 13 • Sayı / Issue 3 • Aralık / December 2021.
8. A Rare Differential Diagnosis of Chronic Urticaria: Monogenic Autoinflammatory Disorders Associated with Urticaria: Cryopyrin-associated Periodic Syndrome and Others. Demir Semra, Gelincik Asli, Öztop Nida, Amikishiyev Shirkhan et al. Urticaria: Interesting Cases 2020:2.
 Hakimli tibbi jurnallarda dərc olunan və beynəlxalq konfranslarda poster təqdimatlar:
1. PRELIMINARY CRITERIA FOR MACROPHAGE ACTIVATION SYNDROME ASSOCIATED WITH CORONAVIRUS DISEASE-19. Amikishiyev Shirkhan, Gunver M, Bektas M, et al. BMJ Publishing Group Ltd; 2021
2. Potential Predictors of Outcome for Anakinra Treatment in COVID-19 Patients with Macrophage Activation Syndrome. Amikishiyev Shirkhan, Deniz R, Gunver M, et al. Arthritis & Rheumatology 2021:3241-3.
3. The Efficacy and Safety of Rituximab in 26 Cases of Treatment Resistant Systemic Sclerosis with Severe Disease Assessed by Activity Scores (6th Systemic Sclerosis World Congress 2020) (P.321; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367)
4. The relationship Between Disease Activity and Severity in Systemic Sclerosis: A Prospective Analysis of 278 Patients (6th Systemic Sclerosis World Congress 2020) (P.147; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367 )
5. Evaluation of Different Classification Criteria in Systemic Sclerosis in a Turkish Cohort: The Importance of Non-Skin Manifestations, Serology and Capillaroscopy (6th Systemic Sclerosis World Congress 2020) (P.148; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367
6. The relationship Between Disease Activity and Severity in Systemic Sclerosis: A Prospective Analysis of 278 Patients (EULAR 2020) (THU0349; http://dx.doi.org/10.1136/annrheumdis-2020-eular.6129 )
7. The Efficacy and Safety of Rituximab in 27 Cases of Treatment Resistant Systemic Sclerosis with Severe Disease Assessed by Activity Scores (EULAR 2020) (STAO346: http://dx.doi.org/10.1136/annrheumdis-2020-eular.6053)
8. Evaluation of Different Classification Criteria in Systemic Sclerosis in a Turkish Cohort: The Importance of Non-Skin Manifestations, Serology and Capillaroscopy (EULAR 2020) (THU369; http://dx.doi.org/10.1136/annrheumdis-2020-eular.6000)
9. Favourable Short-term Course of COVID-19 in Patients with Familial Mediterranean Fever Using Biologic Agents (EULAR 2021) (POS1259; http://dx.doi.org/10.1136/annrheumdis-2021-eular.3903)
10. Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Predominance of Pulmonary Fibrosis as a Risk Factor for Mortality in a Single Center Cohort (EULAR 2021) (ABO448; http://dx.doi.org/10.1136/annrheumdis-2021-eular.3460)
11. Systemic Sclerosis Associated Pulmonary Hypertension: Predominance of Pulmonary Fibrosis as a Risk Factor for Mortality in a Single Center SSC-PH Cohort (7th Systemic Sclerosis World Congress; ID 255)
12. Frequency and Clinical Characteristics of Scleroderma Renal Crisis from Turkey: Most Patients Do Not Have a Treatment History of High Dose Corticosteroids and ACE Inhibitors (7th Systemic Sclerosis World Congress; ID 260)
13. COVID-19 Infections in Patients with Systemic Sclerosis: Factors Associated with Hospitalization (7th Systemic Sclerosis World Congress; ID 260)
 Türkiyə Cümhuriyyəti və digər ölkələrdə konfranslarda sözlü təqdimatlar:
1. PRELIMINARY CRITERIA FOR MACROPHAGE ACTIVATION SYNDROME ASSOCIATED WITH CORONAVIRUS DISEASE-19. Amikishiyev Shirkhan, Gunver M, Bektas M, et al. BMJ Publishing Group Ltd; 2021
2. Potential Predictors of Outcome for Anakinra Treatment in COVID-19 Patients with Macrophage Activation Syndrome. Amikishiyev Shirkhan, Deniz R, Gunver M, et al. Arthritis & Rheumatology 2021:3241-3.
3. COVID-19-İlişkili Makrofaj Aktivasyon Sendromlu Hastalarda Anakinra Tedavisine YanıtıÖngörebilecek Bulguların Araştırılması (2021, Romatolojide Hedef 2021 Sempozyumu, Türkiyə) (SS-10; Ulusal Romatoloji Dergisi Romatolojide Hedef 2021 Sempozyumu Bildiri Özetleri / 27-30 Ekim 2021)
4. COVID-19-İlişkili Makrofaj Aktivasyon Sendromunda Dinamik Laboratuvar DeğişikliklerininHesaplanmasıMehmet Guven Gunver1, Shirkhan Amikishiyev2 (2021, Romatolojide Hedef 2021 Sempozyumu, Türkiyə) (SS-06; Ulusal Romatoloji Dergisi Romatolojide Hedef 2021 Sempozyumu Bildiri Özetleri / 27-30 Ekim 2021)
5. Ciddi vasküler hasar nedeniyle spesifik vazodilatör kullanan Sistemik skleroz hastalarının klinik ve tedavi özellikleri (Ulusal Romatoloji Buluşması 2020, Türkiyə)
6. Meningokok ve Tetanoz Aşı Sonrası Gelişen Katatoni ve Pulmoner Emboli Kliniği ile Tanı Konulan Erişkin Tip Multisistemik İnflamatuvar Sendrom Olgusu. (2021, Olgularla İnflamasyon Multidisipliner Yaklaşım, Türkiyə)
7. Sistemik Skleroz Seyrinde Konstitusyonel Bulgular ve Akut Faz Yüksekliği ile Başvuran Renal Karsinom Olgusu (2021, Olgularla İnflamasyon Multidisipliner Yaklaşım, Türkiyə) (SS-016)
8. Silikozis İlişkili Otoimmün Hastalıklar ve Anakinra Tedavisinin Anti-inflamatuvar Etkinliği. (5. Ulusal Romatoloji kongre bildiri PS-138). Çiğdem Çetin1, Elif Altundaş Hatman2 ,Shirkhan Amikishiyev1 Yasemin Yalçınkaya1, Lale Öcal1, Murat İnanç1, Bahar Artım Esen1, Esen Kıyan3, Zeki Kılıçaslan3, Ahmet Gül1
9. Sistemik Skleroz Hastalarında COVID-19 İnfeksiyonu sıklığı ve Seyri: Tek Merkez Deneyimi (2021, Romatolojide Hedef 2021 Sempozyumu, Türkiyə) (SS-11; Ulusal Romatoloji Dergisi Romatolojide Hedef 2021 Sempozyumu Bildiri Özetleri / 27-30 Ekim 2021)
10. Biyolojik Tedavi Kullanan Ailevi Akdeniz Ateşi Hastalarında COVID-19 İnfeksiyonu Seyri: Tek Merkez Deneyimi (2021, Romatolojide Hedef 2021 Sempozyumu, Türkiyə) (SS-12; Ulusal Romatoloji Dergisi Romatolojide Hedef 2021 Sempozyumu Bildiri Özetleri / 27-30 Ekim 2021)
11. Multiple myelom tanısı ile otolog an kök hücre nakli olgularında infeksiyon sıklığı ve tipi; tek merkez deneyimi (İç xəstəliklərini bitirmə və uzmanlıq tezim, 2017-ci ild Ulusal Hematologiya kongresində poster sunumu).